Neridronic acid

Neridronic acid

Neridronic acid is a bisphosphonate medication primarily used in the treatment of osteoporosis and other bone diseases. It is known for its ability to inhibit bone resorption, which is the process by which bone is broken down and its minerals released into the bloodstream.

Mechanism of Action

Neridronic acid works by binding to hydroxyapatite found in bone, inhibiting the action of osteoclasts, the cells responsible for bone resorption. This leads to a decrease in bone turnover, helping to maintain or increase bone density and strength.

Medical Uses

Neridronic acid is used in the treatment of several conditions, including:

• Osteoporosis
• Paget's disease of bone
• Complex Regional Pain Syndrome (CRPS)
• Osteogenesis imperfecta

Administration

Neridronic acid is typically administered via intravenous infusion. The dosage and frequency of administration depend on the specific condition being treated and the patient's overall health status.

Side Effects

Common side effects of neridronic acid include:

• Hypocalcemia
• Flu-like symptoms
• Gastrointestinal disturbances
• Musculoskeletal pain

Contraindications

Neridronic acid should not be used in patients with:

• Severe renal impairment
• Hypersensitivity to bisphosphonates

Pharmacokinetics

After intravenous administration, neridronic acid is rapidly distributed to the bone. It has a long half-life due to its strong affinity for bone tissue, which allows for infrequent dosing schedules.

Research and Development

Neridronic acid is currently being studied for its potential use in other bone-related conditions and diseases. Ongoing research aims to better understand its efficacy and safety profile in various patient populations.

See Also

• Bisphosphonate
• Osteoporosis
• Paget's disease of bone
• Complex Regional Pain Syndrome
• Osteogenesis imperfecta